Evogene Stock Price on May 19, 2025

EVGN Stock  USD 1.36  0.06  4.62%   
If you're considering investing in Evogene Stock, it is important to understand the factors that can impact its price. As of today, the current price of Evogene stands at 1.36, as last reported on the 24th of July, with the highest price reaching 1.36 and the lowest price hitting 1.30 during the day. Evogene appears to be abnormally volatile, given 3 months investment horizon. Evogene secures Sharpe Ratio (or Efficiency) of 0.0696, which denotes the company had a 0.0696 % return per unit of risk over the last 3 months. By reviewing Evogene's technical indicators, you can evaluate if the expected return of 0.96% is justified by implied risk. Please utilize Evogene's Coefficient Of Variation of 1184.08, downside deviation of 6.71, and Mean Deviation of 5.6 to check if our risk estimates are consistent with your expectations.
At this time, Evogene's Liabilities And Stockholders Equity is very stable compared to the past year. As of the 24th of July 2025, Stock Based Compensation is likely to grow to about 1.9 M, while Common Stock Shares Outstanding is likely to drop about 5.4 M. . As of the 24th of July 2025, Price To Sales Ratio is likely to drop to 1.29. In addition to that, Price Earnings Ratio is likely to grow to -0.67. Evogene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Price Book
4.7059
Enterprise Value Ebitda
(0.81)
Price Sales
1.6747
Shares Float
6.6 M
Wall Street Target Price
3.5

Related Headline

Compugen Headline on 19th of May 2025

Compugen initiated a trial for COM701 therapy in ovarian cancer and continues recruitment for the GS-0321 Phase 1 trial. AstraZeneca expanded ril

Evogene Valuation on May 19, 2025

It is possible to determine the worth of Evogene on a given historical date. On May 19, 2025 Evogene was worth 1.31 at the beginning of the trading date compared to the closed value of 1.34. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Evogene stock. Still, in general, we apply an absolute valuation method to find Evogene's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Evogene where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Evogene's related companies.
 Open High Low Close Volume
  1.23    1.35    1.23    1.31    116,358  
05/19/2025
  1.31    1.36    1.28    1.34    50,478  
  1.36    1.43    1.27    1.27    96,197  
Backtest Evogene  |  Evogene History  |  Evogene Valuation   PreviousNext  
Open Value
1.31
1.34
Closing Value
42.49
Upside

Evogene Trading Date Momentum on May 19, 2025

On May 20 2025 Evogene was traded for  1.27  at the closing time. The top price for the day was 1.43  and the lowest listed price was  1.27 . The trading volume for the day was 96.2 K. The trading history from May 20, 2025 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 5.22% . The overall trading delta against the current closing price is 16.42% .

Evogene Fundamentals Correlations and Trends

By evaluating Evogene's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Evogene's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Evogene financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Evogene Stock history

Evogene investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Evogene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Evogene will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Evogene stock prices may prove useful in developing a viable investing in Evogene
Last ReportedProjected for Next Year
Common Stock Shares Outstanding5.7 M5.4 M
Net Loss-24 M-25.2 M

Evogene Quarterly Net Working Capital

902,000

Evogene Stock Technical Analysis

Evogene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Evogene technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Evogene trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Evogene Period Price Range

Low
July 24, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Evogene cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Evogene July 24, 2025 Market Strength

Market strength indicators help investors to evaluate how Evogene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Evogene shares will generate the highest return on investment. By undertsting and applying Evogene stock market strength indicators, traders can identify Evogene entry and exit signals to maximize returns

Evogene Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Evogene's price direction in advance. Along with the technical and fundamental analysis of Evogene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Evogene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Evogene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evogene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evogene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evogene Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evogene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Evogene Stock, please use our How to Invest in Evogene guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evogene. If investors know Evogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.51)
Revenue Per Share
1.104
Quarterly Revenue Growth
(0.42)
Return On Assets
(0.35)
Return On Equity
(0.91)
The market value of Evogene is measured differently than its book value, which is the value of Evogene that is recorded on the company's balance sheet. Investors also form their own opinion of Evogene's value that differs from its market value or its book value, called intrinsic value, which is Evogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evogene's market value can be influenced by many factors that don't directly affect Evogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.